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Background: The aim of this study was to evaluate the value of T1/T2-weighted imaging (T1/T2WI)
registration to reduce the postbiopsy hemorrhage effect for prostate cancer localization on prostate
magnetic resonance imaging (MRI).
Methods: Twenty-one men with pathology-proven prostate cancer who underwent preoperative MRI in
a single institution were selected. The zonal anatomy was divided into 16 sections. T2WI, T1/T2-weighted
registered imaging (T1/T2RI), T2WI combined with diffusion-weighted imaging (T2WIþDWI), and T1/
T2RI combined with DWI (T1/T2RIþDWI) were scored for the likelihood of cancer by two radiology
faculty members and two trainees, and were compared with histology results. Areas under the receiver
operating characteristics curve (AUCs) were used to assess diagnostic accuracy.
Results: For the trainees (Reader 3 and Reader 4), the AUC values were signiﬁcantly higher (P< 0.05) for
T1/T2RI (0.60 and 0.62, respectively) than for T2WI (0.54 and 0.56, respectively) in tumor detection,
whereas no signiﬁcant difference was observed for faculty members. There was no signiﬁcant difference
in AUC values between T1/T2RI and T2WIþDWI for all readers except for Reader 1. There was no
additional diagnostic beneﬁt for adding DWI with T1/T2RI for all readers.
Conclusions: T1/T2WI registration is a feasible technique. For less experienced readers, T1/T2RI is better
than T2WI in localization of prostate cancer.
Copyright © 2015 Asian Paciﬁc Prostate Society, Published by Elsevier. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The need for the early detection and localization of prostate
cancer based on noninvasive magnetic resonance imaging (MRI)
has increased with the emergence of local targeted therapies as
alternatives to radical prostatectomy or radiation therapy.1e4
However, despite the expectations that MRI would be useful fory, Seoul National University
ndang Hospital, Number 300,
463-707, South Korea.
ciﬁc Prostate Society, Published bprimary detection and localization of prostate cancer, it is an un-
satisfactory imaging modality because of its limited diagnostic ac-
curacy. Therefore, MRI is currently performed for local staging of
prostate cancer conﬁrmed by transrectal ultrasonography-guided
biopsy beforehand. However, this routine diagnostic process of
prostate cancer has the additional negative effect of reducing the
diagnostic performance of prostate MRI owing to postbiopsy
hemorrhage. Postbiopsy hemorrhage presents hypointensity on T2-
weighted imaging (T2WI) similar to the signal intensity of typical
prostate cancer. Although several investigators have reported
variousmethods and imaging techniques for reducing the inﬂuence
of postbiopsy hemorrhage on T2WI,5e8 it is still a major problem for
localization of the prostate cancer on MRI.y Elsevier. This is an open access article under the CC BY-NC-ND license (http://
You et al / Value of T1/T2-weighted imaging registration: cancer vs. hemorrhage 81T1-weighted imaging (T1WI) is often helpful for distinguishing
hemorrhage from background tissue, although abnormal lesion
such as prostate cancer is indistinguishable due to its poor tissue
contrast. Thus, we hypothesized that if we could automatically
suppress the signal intensity of hemorrhage on T2WI using its T1
signal intensity, T2 signal intensity of the prostate cancer would be
more conspicuous and the diagnostic performance of prostate MRI
would be improved. This hypothesis has motivated investigation of
the potential usefulness of imaging registration technique by
summation of the different signal intensities of hemorrhage from
T1WI and T2WI (Fig. 1).
Therefore, we aimed to evaluate the feasibility of T1/T2WI
registration technique for reducing the postbiopsy hemorrhage
effect on prostate MRI and to assess the diagnostic accuracy of T1/
T2-weighted registered imaging (T1/T2RI) for detecting prostate
cancer in comparison with T2WI, T2WI combined with diffusion-
weighted imaging (T2WIþDWI), and T1/T2RI combined with DWI
(T1/T2RIþDWI) in the same patients. Histopathologic sections
were used as the reference standard.
Materials and methods
Study populations
Our institutional review board approved this retrospective
study and waived the requirement for informed consent. We
enrolled 25 men who underwent 1.5-T prostate MRI for the local
staging of prostate cancer in a single institution from March to
October 2009. The inclusion criteria were as follows: (1) patients in
whom prostate cancer had been conﬁrmed by transrectal ultraso-
nography-guided biopsy within 2 months before undergoing MRI,
and in whom radical prostatectomy was performed; (2) patients
who had available T1/T2RI generated using an in-house software
program, and (3) patients who had available reconstructed whole-
mount step-section pathologic tumor maps using an in-house
software program after prostatectomy. We excluded patients (1)
who had previous prostate cancer treatment or (2) for whom
technical problems had interfered with the use of software pro-
grams. Among the 25 patients, four were excluded due to the
following reasons: technical error of in-house software program
(n¼ 3) and previous history of hormone therapy (n¼ 1). As a result,
21 patients (mean age, 68 years ± 5 years; range, 60e75 years) who
satisﬁed the criteria were included for analysis.
MRI protocol
MRI was performed on a 1.5-T scanner (Gyroscan Intera 1.5-T,
Philips Medical Systems, Best, The Netherlands) using a pelvic
phased-array coil (SENSE-Flex-M coil, Philips Medical Systems).
According to the standard prostate MRI protocol at our institution,
the images were obtained including transverse T2-weighted
[repetition time/echo time (TR/TE), 5,900e6,100/120 ms; sectionFig. 1. The basic concept of T1/T2-weighted imaging (T1/T2WI) registration. The signal inte
different on T1WI. To reduce the hemorrhage effect on T2WI, any T1 signal intensity abov
technique. After undergoing this process, T2 signal intensity of the prostate cancer would bthickness, 4 mm; intersection gap, 1 mm; ﬁeld of view,
150 150mm;matrix, 512 512; number of excitations, 3] and T1-
weighted fast spin-echo sequences (TR/TE, 425e600/8e10 ms;
section thickness, 4 mm; intersection gap, 1 mm; ﬁeld of view,
150  150 mm; matrix, 512  512; number of excitations, 3). DWI
was performed using a single-shot echo-planar imaging technique
(b value¼ 0 and 1,000 s/mm2) in the axial plane (TR/TE,
2,600e4,000/81 ms; section thickness, 5 mm; intersection gap,
1 mm; ﬁeld of view, 220  220 mm; matrix, 256  256; number of
excitations, 6 or 14).
Imaging registration processing
T1/T2RI was generated based on routine spin-echo sequences of
T1WI and T2WI using the Prostate Fusion Tool software program,
which was developed in the Visual Computing and Medical Imaging
Laboratory (VCMI Lab) at the College of Information andMedia, Seoul
Women’s University, Korea (Fig. 2). Using this program, any signal
intensity over a selected threshold value onT1WIwas superimposed
onT2WIwithin the speciﬁed boundary. In our study,we use theﬁxed
threshold value of T1 signal intensity. The ﬁxed optimal threshold
value of T1 signal intensity was selected by a preliminary test using
sample data, which was not included in our study.
Image analysis and interpretation
T2WI, T1/T2RI, and DWI were evaluated on a Picture Archiving
and Communication Systems workstation (INFINITT Technology,
Seoul, Korea). All images were reviewed by four radiologists,
including two faculty members (H.J.L. and S.I.H., who had >20 years
of experience and 16 years of experience interpreting prostate MRI,
respectively) and two trainees (Y.J.B. and J.Y.Y., who are residents
having 3 years of radiology experience). Although the readers were
aware that the patients had prostate cancer, they were blinded to
clinical data and pathologic results. They were provided with a
description of the principle of image registration and some
example before imaging interpretation.
T2WI, T1/T2RI, T2WIþDWI, and then T1/T2RIþDWI were
independently reviewed. The imaging quality of T1/T2RI was
analyzed according to three categories as follows: (1) good (no
artifact); (2) adequate (the presence of minor image-degrading
artifacts but feasible for imaging interpretation with moderate
conﬁdence); and (3) poor (the presence of major image-degrading
artifacts enough to disturb imaging interpretation).
The zonal anatomy of the prostate was divided into 16 regions,
modiﬁed from the result of the 2011 European ConsensusMeeting.9
First, the prostate was divided into the base, middle, and apex re-
gions. According to the description by Haider et al,10 the base was
deﬁned as the region extending from the most superior margin to
the widest transverse diameter of the prostate. The middle was
deﬁned as the region between the widest transverse diameter of
the prostate and the oriﬁces of the ejaculatory ducts at thensity of hemorrhage (H) is same as that of prostate cancer (C) on T2WI; however, it is
e a selected threshold value is superimposed on T2WI using the imaging registration
e more conspicuous, whereas that of the hemorrhage would be suppressed.
Fig. 2. Software program for T1/T2-weighted imaging (T1/T2WI) registration. Using the Prostate Fusion Tool software program, T1/T2-weighted registered imaging (A) is generated
by designating a region of interest with four or more points on T2WI (B) and (C) T1WI. (D) Finally, T1/T2-weighted registered imaging can be compared with a photomicrograph of
pathologic specimen.
Prostate Int 3 (2015) 80e8682verumontanum. The apex was deﬁned as the region inferior to the
mid-region. The central gland comprising the transition zone and
central zonewas additionally divided into left and right halves from
the base to apex, yielding six regions. The peripheral zone of the
prostate was subdivided into four quarters (left lateral, left medial,
right medial, and right lateral areas) at the middle and base,
whereas it was subdivided into left and right halves at the apex.
Thus, the middle and base of the prostate were composed of six
regions each and the apex was composed of four regions. The re-
viewers assigned a score to each local region for the likelihood of
cancer using the following 5-point index scale: 0, deﬁnitely no
cancer; 1, probably no cancer; 2, possible cancer; 3, probable can-
cer; and 4, deﬁnite cancer.
Histopathologic analysis and image correlation
The prostate specimens were embedded in formalin after
prostatectomy and then sliced from the apex to the base at 3e4-
mm intervals. These slices were sectioned into two halves or four
quarters to ﬁt on a standard slide. An uropathologist (G.Y.C.) with
over 25 years of experience outlined the region of cancer before it
was digitally imaged. All sectioned slides were digitized and
reconstructed into whole-mount sections automatically using the
Pathology Stitching and Correction Tool software program, which
was developed by the VCMI Lab at the College of Information and
Media, Seoul Women's University, Korea. The region was consid-
ered positive for cancer if it contained tumor with a cross-sectional
area that was greater than 0.5 cm2 on the ﬁxed specimen and a
Gleason score of 6 or higher.
For the purpose of radiologicepathologic correlation, a radiolo-
gist reviewed thepathologic specimens inconjunctionwithMRI.MRI
and pathologic step-section slices were paired based on anatomic
landmarks and the approximate distance from the base or apex.Statistical analyses
All the statistical analyses were performed using commercially
available software (SPSS, version 18, 2010; SPSS, Chicago, IL, USA). P
values less than 0.05 were considered statistically signiﬁcant.
Receiver operating characteristic curves were estimated separately
for each region of the prostate using the maximum likelihood. The
area under the receiver operating characteristics curve (AUC) of T1/
T2RI was compared with T2WI, T2WIþDWI, or T1/T2RIþDWI for
each reader. The diagnostic accuracy was estimated for differences
between methods by choosing a threshold score of 2 or higher to
indicate cancer, together with 95% conﬁdence intervals (CIs),
separately for each reader. Interobserver agreement was evaluated
using the k statistic, which was interpreted based on the criteria of
Landis and Koch.11
Results
The patients' characteristics are summarized in Table 1. Of the
total 336 regions in 21 patients, 120 contained cancers that were
greater than 0.5 cm2 with a Gleason score of 6 or higher. Among
them, 67 cancers (55.8%) were located in the peripheral zone. The
mean interval fromMRI to surgery was 19 days (range, 7e38 days).
In analysis of the imaging quality of T1/T2RI, all cases were classi-
ﬁed into either adequate or good categories by all readers.
For faculty members, Reader 1 and Reader 2, no signiﬁcant
improvement of T1/T2RI (AUC values of 0.60 and 0.62, respectively)
was observed in tumor detection compared with T2WI (AUC values
of 0.60 and 0.62, respectively). However, the AUC values of T1/T2RI
were signiﬁcantly higher than those of T2WI for the trainees,
Reader 3 (0.60 and 0.54, respectively, P¼ 0.03) and Reader 4 (0.62
and 0.56, respectively, P¼ 0.04; Fig. 3). As a result of adding DWI on
T2WI, the AUC value of T2WIþDWI was signiﬁcantly higher than
Table 2
Diagnostic accuracy of T2-weighted imaging versus T1/T2-weighted registered
imaging for prostate cancer.a)
T2WI T1/T2RI P
Reader 1 59.23% (53.98e64.48)b) 53.27% (47.97e58.60) 0.088
Reader 2 64.58% (59.47e69.67) 64.29% (59.1e69.41) >0.99
Reader 3 58.63% (53.36e63.90) 65.77% (60.70e70.84) 0.002
Reader 4 52.98% (47.64e58.32) 63.69% (58.55e68.83) <0.001
a) Regions scored as 2 or higher were considered positive.
b) The 95% conﬁdence intervals are shown in parentheses.




Mean age (yr) 68 (60e75)











Interval between biopsy and MRI (d)
14 N¼ 9
>14 N¼ 12
Mean tumor volume 14 (1e80%)
Number of tumor nodulesa)
In peripheral zone 67 (55.8%)
In central zone 53 (44.2%)
a) Tumor nodule was counted if it was greater than 0.5 cm2 on the ﬁxed specimen
with a Gleason score of 6 or higher.
MRI, magnetic resonance imaging; PSA, prostate-speciﬁc antigen.
You et al / Value of T1/T2-weighted imaging registration: cancer vs. hemorrhage 83that of T2WI for three of four readers. However, there was no
additional beneﬁt for adding DWI on T1/T2RI in tumor detection for
all readers. When comparing AUC values between T2WIþDWI and





















































































Fig. 3. Receiver operating characteristic curves for detection of prostate cancer on T2-weigh
line). (A) For Reader 1, areas under the curve (AUCs) of both T2WI and T1/T2RI were 0.60 wi
T2RI were 0.62 without statistical signiﬁcance (P¼ 0.97). (C) For Reader 3, the AUC was sign
Reader 4, the AUC was signiﬁcantly higher (P¼ 0.04) for T1/T2RI (AUC¼ 0.62) than for T2WT2WIþDWI than for T1/T2RI (0.68 and 0.60, respectively, P¼ 0.02),
whereas others showed no signiﬁcant difference between
T2WIþDWI and T1/T2RI.
The diagnostic accuracy of all readers is summarized in Tables 2
and 3, using a threshold score of 2 or higher to indicate cancer. For
trainees, the diagnostic accuracy was signiﬁcantly higher for T1/
T2RI than for T2WI (P¼ 0.002 and P< 0.001 for Reader 3 and
Reader 4, respectively; Figs. 4 and 5). Especially for Reader 4, the
diagnostic accuracy was signiﬁcantly higher for T1/T2RI than for
T2WI without overlap of the CIs [63.69%, (58.55e68.83); 95% CI vs.
52.98%, (47.64e58.32); 95% CI, P< 0.001]. When comparing diag-
nostic accuracy between T2WIþDWI and T1/T2RI, no signiﬁcant
difference was observed for all readers except for Reader 1




























ted imaging (T2WI; dotted line) and T1/T2-weighted registered imaging (T1/T2RI, solid
thout statistical signiﬁcance (P¼ 0.93). (B) For Reader 2, the AUCs of both T2WI and T1/
iﬁcantly higher (P¼ 0.03) for T1/T2RI (AUC¼ 0.60) than for T2WI (AUC¼ 0.54). (D) For
I (AUC¼ 0.56).
Table 3
Diagnostic accuracy of T2-weighted imaging combined with diffusion-weighted
imaging versus T1/T2-weighted registered imaging for prostate cancer.a)
T2WIþDWI T1/T2RI P
Reader 1 66.37% (61.31e71.42)b) 53.27% (47.97e58.60) 0.001
Reader 2 66.96% (61.93e71.99) 64.29% (59.1e69.41) 0.507
Reader 3 61.31% (56.10e66.52) 65.77% (60.70e70.84) 0.276
Reader 4 70.24% (65.35e75.13) 63.69% (58.55e68.83) 0.084
a) Regions scored as 2 or higher were considered positive.
b) The 95% conﬁdence intervals are shown in parenthesis.
T2WIþ DWI, T2-weighted imaging combined with diffusion-weighted imaging; T1/
T2RI, T1/T2-weighted registered imaging alone.
Prostate Int 3 (2015) 80e8684For all readers, the diagnostic accuracy between T1/T2RI and T1/
T2RIþDWI was not found to have a signiﬁcant difference.
The interobserver agreement for the detection of prostate can-
cer was all moderate on T2WI, T1/T2RI, T2WIþDWI, and T1/
T2RIþDWI with kappa values of 0.47e0.58 among all readers.Discussion
The imaging registration technique is widely used in radiologic
ﬁelds such as breast dynamic contrast-enhanced MRI and MR
angiography to improve the lesion detection rate. This technique is
usually applied for differentiating one from surrounding tissue or
for monitoring the interval change of the subject in serial follow-
up. It is routinely used in rigid organs such as the brain; however, its
use is less common in movable body organs.12e14 Imaging regis-
tration in the prostate, which is a relatively nonmovable and rigid
organ, has been described in several publications, often for mea-
surement of the prostate volume, guidance of image-based local-
ized therapy, or fusion between MRI and the histologicFig. 4. High speciﬁcity of T1/T2-weighted registered imaging in a 74-year-old manwith pros
peripheral zone (arrow). It was scored as greater than 2 (possible cancer) by three reade
suggestive of hemorrhage. (C) After data processing, focal T2 low signal intensity in the sam
0 or 1 by all readers. (D) Finally, tumor is not identiﬁed on the pathologic specimen (hemaspecimen.15e18 To the best of our knowledge, the imaging regis-
tration technique has not yet been used as a potential technique for
reducing the postbiopsy hemorrhage effect on prostate MRI.
Hypointensity of prostate cancer on T2WI is difﬁcult to distin-
guish from that of prostatitis, benign prostatic hypertrophy, or
postbiopsy hemorrhage.19 Among these factors, postbiopsy hem-
orrhage has the greatest ability to interfere with localizing the
cancer on T2WI. Several authors proposed adjusting the time in-
terval between biopsy and MRI to eliminate the inﬂuence of post-
biopsy hemorrhage on MRI.5e7,20 However, this approach was not
effective due to individual variation during the period of a full
resolution of postbiopsy hemorrhage. Postbiopsy hemorrhage is
inevitable on MRI in the current diagnostic process of prostate
cancer. Barrett et al8 rather attempted to use postbiopsy hemor-
rhage for detection of prostate cancer with the hemorrhage
exclusion sign on T1WI. In our study, we used the imaging regis-
tration technique for reducing postbiopsy hemorrhage effect on
T2WI, based on the difference of the signal intensity on T1WI be-
tween cancer and hemorrhage.
Our results showed that the T1/T2WI registration techniquewas
feasible for reducing the effect of postbiopsy hemorrhage on T2WI.
In cases with obvious postbiopsy hemorrhage, hemorrhage was
often misdiagnosed as prostate cancer on T2WI. This is more
common with less experienced readers, although it was not sta-
tistically signiﬁcant. In those cases, hypointensity of hemorrhage on
T2WI was completely corrected using the image registration
technique, and therefore, it showed almost the same signal in-
tensity as the surrounding normal prostate tissue on T1/T2RI
(Fig. 4). In cases with a small amount of postbiopsy hemorrhage,
tumor extent is sometimes overestimated because of partially
overlapped hemorrhage. In those cases, hypointensity of the
prostate cancer becamemore conspicuous with clear margin on T1/tate cancer. (A) T2-weighted imaging shows focal low signal intensity in the right lateral
rs. (B) T1-weighted imaging shows focal high signal intensity in that region (arrow),
e region (arrow) is suppressed on T1/T2-weighted registered imaging. It was scored as
toxylineeosin stain; original magniﬁcation, 1) in the corresponding region (arrow).
Fig. 5. Good conspicuity of prostate cancer on T1/T2-weighted registered imaging in a 67-year-old man. (A) T2-weighted imaging shows suspicious focal low signal intensity in the
right posterior peripheral zone at the apex of the prostate (arrow). The interobserver agreement for this region was poor because it was unclear. (B) T1-weighted imaging shows
focal high signal intensity in that region (arrow), suggestive of partial hemorrhage. (C) After data processing, this lesion is shown as a more conspicuous low signal intensity region
with the relatively clear margin of the tumor (arrow) on T1/T2-weighted registered imaging. (D) A photomicrograph of the pathologic specimen (hematoxylineeosin stain; original
magniﬁcation, 1) shows a tumor with Gleason score of 7 (outlined area with arrow) in the corresponding region.
You et al / Value of T1/T2-weighted imaging registration: cancer vs. hemorrhage 85T2RI than that on T2WI, because the partially overlapped hemor-
rhage was suppressed using the image registration technique
(Fig. 5). Furthermore, the quality of T1/T2RI was acceptable for
interpretation without severe misregistration artifact. Although
there was the interface artifact between the hemorrhage and sur-
rounding tissue in some cases, it was minor and negligible. The
quality of T1/T2RI seems to be decided by the qualities of the
routine T1WI and T2WI.
Another noticeable ﬁnding in our study was that the AUC values
for T1/T2RI were signiﬁcantly higher in detection and localization
of prostate cancer in comparison with T2WI for radiology trainees
[AUC value of 0.54 (T2WI) and 0.60 (T1/T2RI) for Reader 3, AUC
value of 0.56 (T2WI) to 0.62 (T1/T2RI) for Reader 4, P< 0.05]. The
experience level of radiologists can affect diagnostic performance
with any imaging study. In particular, interpretation of prostateMRI
is even more inﬂuenced by the reader experience.21e25 However,
from our results, T1/T2RI could decrease this difference by
improving diagnostic performance of less experienced readers. Less
experienced readers had difﬁculty in distinguishing tumor from
adjacent overlapped hemorrhage on T2WI because of lack of
experience and unfamiliarity with minute morphologic differences
between prostate cancer and hemorrhage. However, T1/T2RI is
relatively more intuitive than T2WI by automatic subtraction of
hemorrhage. It might help them identify the margin of tumors
more clearly. Therefore, we think that T1/T2RI can be a good
alternative option to improve diagnostic accuracy to localize
prostate cancer for less experienced readers such as general radi-
ologists or urologists.
In addition, there was no signiﬁcant difference in diagnostic
accuracy between T2WIþDWI and T1/T2RI. Unlike DWI, T1/T2RI
does not require additional scan. T1/T2RI can be simply generatedbased on routine spin-echo T1WI and T2WI with postprocessing
program. Therefore, it is easy to implement as a potential useful
technique in the clinics. Theoretically, use of T1/T2RI can shorten
the interpretation time and increase diagnostic conﬁdence
compared with side-by-side interpretation of T2WI and T1WI,
which is the method performed in routine practice.
Our study had several limitations. First, this was a small retro-
spective study using 1.5-T MRI. Second, we used a pelvic phased-
array coil on prostate MRI. Although higher signal-to-noise ratio
could be achieved using an endorectal coil, we do not routinely use
it at our institution because of patient discomfort. Third, misreg-
istration artifacts were identiﬁed in some cases, even though they
were all minor. Finally, although we tried to match MRI with
pathology maps using anatomical landmark, the radio-
logicepathologic correlation was still ambiguous. Despite these
limitations, this is the ﬁrst try to use the image registration tech-
nique for reducing postbiopsy hemorrhage effect in localization of
prostate cancer. However, further large prospective studies are
required to conﬁrm the clinical value of T1/T2RI in localization of
prostate cancer. If this procedure is successful, it can be a useful
problem-solving technique and will help urologists recognize the
tumor location preoperatively.
In conclusion, T1/T2WI registration is a feasible technique for
reducing the postbiopsy hemorrhage effect. For less experienced
readers, T1/T2RI is better than T2WI in localization of prostate
cancer.Conﬂicts of interest
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